|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0070 | ED149562 | General Research Use | No | Male | White | 70 | 7 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0137 | ED148327 | General Research Use | No | Female | White | 82 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0143 | ED148982 | General Research Use | No | Male | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0508 | ED148881 | General Research Use | No | Male | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0711 | ED149421 | General Research Use | No | Female | White | 80 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0771 | ED149209 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1060 | ED150013 | General Research Use | No | Male | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1205 | ED148720 | General Research Use | No | Male | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1246 | ED148503 | General Research Use | No | Male | White | 69 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1303 | ED149490 | General Research Use | No | Male | White | 79 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1584 | ED148760 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1984 | ED149405 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2035 | ED148717 | General Research Use | No | Male | White | 76 | 7 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2039 | ED148729 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2139 | ED149406 | General Research Use | No | Male | White | 55 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2151 | ED149051 | General Research Use | No | Male | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2245 | ED148632 | General Research Use | No | Male | White | 77 | 7 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2486 | ED149187 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2530 | ED148971 | General Research Use | No | Female | White | 82 | 7 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2696 | ED149974 | General Research Use | No | Female | White | 73 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |